Conference Coverage

Survey Spotlights Identification of Dermatologic Adverse Events From Cancer Therapies

Publish date: May 13, 2024

 

FROM AAD 2024

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

Time to Lung Disease in Patients With Dermatomyositis Subtype Estimated
MDedge Dermatology
Sunscreen Safety: 2024 Updates
MDedge Dermatology
A Structured Approach for the Management of Orodynia (Burning Mouth Syndrome)
MDedge Dermatology
Terminal Cancer: What Matters to Patients and Caregivers
MDedge Dermatology
Do Health-Related Social Needs Raise Mortality Risk in Cancer Survivors?
MDedge Dermatology
Do Patients Benefit from Cancer Trial Participation?
MDedge Dermatology
Study Evaluates CVD, Mortality Risks In Patients With Prurigo Nodularis
MDedge Dermatology
Growing Periumbilical Plaque: A Case of Perforating Calcific Elastosis
MDedge Dermatology
Can a Risk Score Predict Kidney Injury After Cisplatin?
MDedge Dermatology
New mRNA Vaccines in Development for Cancer and Infections
MDedge Dermatology